The Food and Drug Administration announced Monday that it has approved a new Johnson & Johnson treatment for patients with multidrug-resistant tuberculosis. This is the first new medicine to treat the disease in 40 years.
The FDA has approved a drug to help prevent high-risk people from contracting the HIV virus. The drug, which is called Truvada, is meant to be used by people who engage in sexual activity with HIV infected partners, BBC News reports.
